Melin­ta chief John John­son jumps ship — with the chair­man — from an­oth­er trou­bled an­tibi­otics play

Just 9 months af­ter tak­ing the reins at Melin­ta, the ex­pe­ri­enced biotech ex­ec John John­son is whirling back out through the re­volv­ing door to the C suite at the trou­bled an­tibi­otics com­pa­ny.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER